Funding for this research was provided by:
ministry of health and welfare (HI15C1200, HC19C0130)
Received: 15 June 2021
Accepted: 10 December 2021
First Online: 8 March 2022
: This study was approved by the Institutional Review Board of the Yonsei University Health System (4-2016-0329). The requirement for informed consent was waived because personal identification information was removed after cohort generation, in accordance with the strict confidentiality guidelines.
: Dr. Boyoung Joung has served as a speaker for Bayer, BMS/Pfizer, Medtronic, and Daiichi-Sankyo and received research funds from Medtronic and Abbott. Neither author has received any fees directly. The other authors have nothing to declare.
: All authors have permitted the publication.